Benzimidazoles and isosteric compounds as potent and selective factor Xa inhibitors.
暂无分享,去创建一个
M. Myers | Wei He | A. Spada | D. Colussi | S. Condon | B. Hanney | V. Chu | Karen Brown | M. Becker | C. Burns
[1] W. R. Ewing,et al. The Design of Competitive, Small-molecule Inhibitors of Coagulation Factor Xa , 2001 .
[2] M. Myers,et al. Nonbenzamidine compounds as selective factor Xa inhibitors. , 2000, Bioorganic & medicinal chemistry letters.
[3] C. Dunwiddie,et al. In vitro characterization of a novel factor Xa inhibitor, RPR 130737. , 2000, Thrombosis research.
[4] C. Dunwiddie,et al. Sulfonamidopyrrolidinone factor Xa inhibitors: potency and selectivity enhancements via P-1 and P-4 optimization. , 1999, Journal of medicinal chemistry.
[5] W. R. Ewing,et al. PROGRESS IN THE DESIGN OF INHIBITORS OF COAGULATION FACTOR XA , 1999 .
[6] J. Stürzebecher,et al. Synthetic inhibitors of thrombin and factor Xa: from bench to bedside. , 1999, Thrombosis research.
[7] R. Scarborough. Coagulation factor Xa: the prothrombinase complex as an emerging therapeutic target for small molecule inhibitors. , 1998, Journal of enzyme inhibition.
[8] J. Hauptmann,et al. Factor Xa Inhibitors as Novel Antithrombotic Agents: Facts and Perspectives , 1994 .
[9] J. Prousek. Preparation of 1-(2-benzimidazolyl)-2-substituted ethylene derivatives by the Wittig reaction , 1991 .
[10] A. Berger,et al. Cleavage of N-Carbobenzoxy Groups by dry Hydrogen Bromide and Hydrogen Chloride , 1952 .